NSC |
Compound |
Enrichment |
Correlation |
NSC 728132 |
1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene |
0.0115521552688255 |
0.45656224 |
NSC 736079 |
4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine |
0.0115521552688255 |
0.38794242 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
0.0115521552688255 |
0.35830855 |
NSC 736153 |
Null |
0.0115521552688255 |
0.46493259 |
NSC 742838 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride |
0.0115521552688255 |
0.22117783 |
NSC 758965 |
CEPHARANTHINE |
0.0115521552688255 |
0.16492304 |
NSC 693543 |
4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride |
0.0115521552688257 |
-0.091266227 |
NSC 734148 |
2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester |
0.0115521552688257 |
-0.0084333615 |
NSC 12161 |
Adenosine, 1,2-dihydro-2-oxo- (9CI) |
0.0115521552688258 |
0.090696639 |
NSC 150014 |
Hydrazine dihydrogen sulfate salt |
0.0115521552688258 |
0.54915561 |